Breast cancer drug blocked for NHS use in England and Wales after talks collapse

By The Guardian | Nov 19, 2024 at 03:56 PM EST

Negotiations between National Institute for Health and Care Excellence and Enhertu manufacturers failed, preventing access to the drug for women with terminal breast cancer in England and Wales. This outcome has been deemed a tragic loss by Breast Cancer Now, despite intervention from the health secretary.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.